| n | Events | % | Model 1 | Model 2 | P value for interaction | ||
---|---|---|---|---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | |||||
Gender | Â | Â | Â | Â | Â | Â | Â | 0.122 |
 Male | 5206 | 4056 | 77.91 | 1.07 (1.02, 1.11) | 0.005 | 1.02 (0.96, 1.07) | 0.593 |  |
 Female | 7760 | 5792 | 74.64 | 1.10 (1.06, 1.15) | <0.001 | 1.09 (1.04, 1.14) | <0.001 |  |
Age (years) | Â | Â | Â | Â | Â | Â | Â | 0.129 |
 < 60 | 8846 | 6759 | 76.41 | 1.14 (1.08, 1.20) | <0.001 | 1.11 (1.04, 1.18) | 0.002 |  |
 ≥ 60 | 4120 | 3089 | 74.98 | 1.08 (1.04, 1.11) | <0.001 | 1.03 (0.99, 1.08) | 0.154 |  |
Treatment Group | Â | Â | Â | Â | Â | Â | Â | 0.267 |
 Enalapril only | 6531 | 4960 | 75.95 | 1.08 (1.04, 1.12) | <0.001 | 1.05 (1.00, 1.10) | 0.076 |  |
 Enalapril-Folic Acid | 6435 | 4888 | 75.96 | 1.11 (1.07, 1.16) | <0.001 | 1.07 (1.02, 1.13) | 0.010 |  |
SBP (mmHg) | Â | Â | Â | Â | Â | Â | Â | 0.535 |
 < 127.0 | 4163 | 3088 | 74.18 | 1.11 (1.06, 1.16) | <0.001 | 1.08 (1.01, 1.14) | 0.019 |  |
 127.0 ≤ SBP < 141.3 | 4204 | 3197 | 76.05 | 1.12 (1.07, 1.18) | <0.001 | 1.09 (1.03, 1.16) | 0.006 |  |
 ≥ 141.3 | 4448 | 3447 | 77.5 | 1.07 (1.02, 1.12) | 0.008 | 1.01 (0.95, 1.07) | 0.846 |  |
DBP (mmHg) | Â | Â | Â | Â | Â | Â | Â | 0.083 |
 < 78.0 | 4145 | 3071 | 74.09 | 1.10 (1.05, 1.15) | <0.001 | 1.06 (1.00, 1.12) | 0.069 |  |
 ≥ 78.0, <86.5 | 4392 | 3303 | 75.2 | 1.14 (1.08, 1.20) | <0.001 | 1.09 (1.03, 1.16) | 0.005 |  |
 ≥ 86.5 | 4278 | 3358 | 78.49 | 1.05 (0.99, 1.10) | 0.083 | 1.02 (0.95, 1.08) | 0.618 |  |
DM | Â | Â | Â | Â | Â | Â | Â | 0.834 |
 No | 10,089 | 7623 | 75.56 | 1.10 (1.07, 1.14) | <0.001 | 1.05 (1.01, 1.09) | 0.028 |  |
 Yes | 2412 | 1857 | 76.99 | 1.09 (1.02, 1.15) | 0.009 | 1.07 (0.99, 1.16) | 0.077 |  |